阻断LOXL2与TGFβ1信号在IPF患者精切肺切片中诱导I型胶原周转
本研究在IPF移植患者肺组织来源的精切肺切片中,发现EGCG不仅减弱TGFβ1信号和新胶原积累,还激活基质金属蛋白酶依赖的I型胶原周转,提示持续治疗可能缓慢逆转纤维化。
要点
- EGCG在IPF精切肺切片中减弱TGFβ1信号与新胶原积累
- EGCG激活基质金属蛋白酶依赖的I型胶原周转
- 持续治疗可能促进缓慢的纤维化消退
核心结论
- 在IPF患者精切肺切片中,EGCG同时抑制纤维化信号并激活胶原降解,提示持续治疗可能促进缓慢的纤维化消退。
研究设计与样本
- 使用接受移植的IPF患者肺外植体来源的精切肺切片进行培养实验。
主要发现
- EGCG减弱TGFβ1信号并减少新胶原积累。
- EGCG激活基质金属蛋白酶依赖的I型胶原周转。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We recently identified epigallocatechin gallate (EGCG), a trihydroxyphenolic compound, as a dual inhibitor of lysyl oxidase-like2 and transforming growth factor-β1 (TGFβ1) receptor kinase that when given orally to patients with idiopathic pulmonary fibrosis (IPF) reversed profibrotic biomarkers in their diagnostic biopsies. Here, we extend these findings to advanced pulmonary fibrosis using cultured precision-cut lung slices from explants of patients with IPF undergoing transplantation. During these experiments, we were surprised to discover that not only did EGCG attenuate TGFβ1 signalling and new collagen accumulation but also activated matrix metalloproteinase-dependent collagen I turnover, raising the possibility of slow fibrosis resolution with continued treatment.
引用
- Wei Y, Dong W, Jackson J, et al. Blocking LOXL2 and TGFβ1 signalling induces collagen I turnover in precision-cut lung slices derived from patients with idiopathic pulmonary fibrosis. Thorax. 2021. PMID: 33472968. doi:10.1136/thoraxjnl-2020-215745
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。